These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25790049)

  • 21. Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.
    Malm M; Tamminen K; Lappalainen S; Uusi-Kerttula H; Vesikari T; Blazevic V
    Clin Vaccine Immunol; 2015 Jun; 22(6):656-63. PubMed ID: 25903355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and purification of norovirus virus like particles in Escherichia coli and their immunogenicity in mice.
    Huo Y; Wan X; Ling T; Wu J; Wang W; Shen S
    Mol Immunol; 2018 Jan; 93():278-284. PubMed ID: 28802994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection.
    Blazevic V; Malm M; Vesikari T
    J Med Virol; 2015 Oct; 87(10):1656-61. PubMed ID: 25946711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Norovirus infections and seroprevalence of genotype GII.4-specific antibodies in a Spanish population.
    Carmona-Vicente N; Fernández-Jiménez M; Ribes JM; Téllez-Castillo CJ; Khodayar-Pardo P; Rodríguez-Diaz J; Buesa J
    J Med Virol; 2015 Apr; 87(4):675-82. PubMed ID: 25655810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype.
    Tamminen K; Huhti L; Vesikari T; Blazevic V
    Viral Immunol; 2013 Apr; 26(2):167-70. PubMed ID: 23438469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and characterization of the major capsid protein derived from a GII.6 norovirus strain isolated in China.
    Huo Y; Zheng L; Chen X; Ge L; Wang Y
    Microb Pathog; 2017 Apr; 105():131-137. PubMed ID: 28219831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
    Lindesmith LC; Beltramello M; Donaldson EF; Corti D; Swanstrom J; Debbink K; Lanzavecchia A; Baric RS
    PLoS Pathog; 2012; 8(5):e1002705. PubMed ID: 22615565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological and immunological characterization of norovirus major capsid proteins from three different genotypes.
    Huo Y; Wan X; Ling T; Shen S
    Microb Pathog; 2016 Jan; 90():78-83. PubMed ID: 26616166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice.
    Tamminen K; Lappalainen S; Huhti L; Vesikari T; Blazevic V
    PLoS One; 2013; 8(7):e70409. PubMed ID: 23922988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The endemic GII.4 norovirus-like-particle induced-antibody lacks of cross-reactivity against the epidemic GII.17 strain.
    Du J; Gu Q; Liu Y; Li Q; Guo T; Liu Y
    J Med Virol; 2021 Jun; 93(6):3974-3979. PubMed ID: 32869863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of rabbit antibodies raised against
    Kulkarni R; Lole K; Chitambar SD
    Indian J Med Res; 2017 Dec; 146(6):788-790. PubMed ID: 29664039
    [No Abstract]   [Full Text] [Related]  

  • 32. Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.
    Sharma S; Carlsson B; Czakó R; Vene S; Haglund M; Ludvigsson J; Larson G; Hammarström L; Sosnovtsev SV; Atmar RL; Green KY; Estes MK; Svensson L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analyses of Binding Profiles of the GII. 12 Norovirus with Human Histo-blood Group Antigens].
    Jin M; Chen K; Song J; Li H; Zhang Q; Kong X; Liu N; Duan Z
    Bing Du Xue Bao; 2015 Mar; 31(2):164-9. PubMed ID: 26164942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.
    Parra GI; Abente EJ; Sandoval-Jaime C; Sosnovtsev SV; Bok K; Green KY
    J Virol; 2012 Jul; 86(13):7414-26. PubMed ID: 22532688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High yield production of norovirus GII.4 virus-like particles using silkworm pupae and evaluation of their protective immunogenicity.
    Masuda A; Man Lee J; Miyata T; Sato S; Masuda A; Taniguchi M; Fujita R; Ushijima H; Morimoto K; Ebihara T; Hino M; Kakino K; Mon H; Kusakabe T
    Vaccine; 2023 Jan; 41(3):766-777. PubMed ID: 36528444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevailing Sydney like Norovirus GII.4 VLPs induce systemic and mucosal immune responses in mice.
    Huo Y; Wan X; Ling T; Wu J; Wang Z; Meng S; Shen S
    Mol Immunol; 2015 Dec; 68(2 Pt A):367-72. PubMed ID: 26375574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norovirus-specific mucosal antibodies correlate to systemic antibodies and block norovirus virus-like particles binding to histo-blood group antigens.
    Tamminen K; Malm M; Vesikari T; Blazevic V
    Clin Immunol; 2018 Dec; 197():110-117. PubMed ID: 30244152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroepidemiology of predominant norovirus strains circulating in Korea by using recombinant virus-like particle antigens.
    Son H; Jeong HS; Cho M; Lee J; Lee H; Yoon K; Jeong AY; Jung S; Kim K; Cheon DS
    Foodborne Pathog Dis; 2013 May; 10(5):461-6. PubMed ID: 23627928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymatic cleavage promotes disassembly of GII.3 norovirus virus like particles and its binding to salivary histo-blood group antigens.
    Huo Y; Wang W; Zheng L; Chen X; Shen S; Wang M
    Virus Res; 2017 Aug; 240():18-24. PubMed ID: 28754559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children.
    Malm M; Uusi-Kerttula H; Vesikari T; Blazevic V
    J Infect Dis; 2014 Dec; 210(11):1755-62. PubMed ID: 24970849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.